Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5151
Celularity
CELU
$24.7M
| $5 | ﹤0.01% |
+4
| New | +$4 |
2026 Q3
0 quarters
|
|
5152
ClearOne Inc
CLRO
$13.4M
| $5 | ﹤0.01% |
+1
| New | +$6 |
2026 Q3
0 quarters
|
|
5153
CNS Pharmaceuticals
CNSP
$5.73M
| $5 | ﹤0.01% |
1
-18
| -95% | -$97 |
2026 Q2
1 quarter
|
|
5154
Creative Realities
CREX
$27.5M
| $5 | ﹤0.01% |
2
-44
| -96% | -$134 |
2026 Q2
1 quarter
|
|
5155
DocGo
DCGO
$24.3M
| $5 | ﹤0.01% |
14
-5,286
| -100% | -$2.7K |
2022 Q1
18 quarters
|
|
5156
Fuel Tech
FTEK
$42.1M
| $5 | ﹤0.01% |
+3
| New | +$5 |
2026 Q3
0 quarters
|
|
5157
Good Times Restaurants
GTIM
$13.1M
| $5 | ﹤0.01% |
+3
| New | +$4 |
2026 Q3
0 quarters
|
|
5158
Heritage Global
HGBL
$43.3M
| $5 | ﹤0.01% |
4
-161
| -98% | -$198 |
2026 Q2
1 quarter
|
|
5159
Mediaco Holding
MDIA
$87.4M
| $5 | ﹤0.01% |
+5
| New | +$5 |
2026 Q3
0 quarters
|
|
5160
Motorsport Games
MSGM
$19.5M
| $5 | ﹤0.01% |
+1
| New | +$4 |
2026 Q3
0 quarters
|
|
5161
Processa Pharmaceuticals
PCSA
$5.39M
| $5 | ﹤0.01% |
+3
| New | +$6 |
2026 Q3
0 quarters
|
|
5162
Tao Synergies Inc
TAOX
$20.4M
| $5 | ﹤0.01% |
1
-116
| -99% | -$439 |
2026 Q2
1 quarter
|
|
5163
Health In Tech Inc
HIT
$36.4M
| $5 | ﹤0.01% |
6
-713
| -99% | -$716 |
2026 Q2
1 quarter
|
|
5164
CID HoldCo Inc
DAIC
$2.36M
| $5 | ﹤0.01% |
+2
| New | +$4 |
2026 Q3
0 quarters
|
|
5165
Ainos
AIMD
$5.15M
| $4 | ﹤0.01% |
+3
| New | +$5 |
2026 Q3
0 quarters
|
|
5166
American Shared Hospital Services
AMS
$7.71M
| $4 | ﹤0.01% |
3
-79
| -96% | -$117 |
2026 Q2
1 quarter
|
|
5167
Bridger Aerospace
BAER
$11.5M
| $4 | ﹤0.01% |
+5
| New | +$7 |
2026 Q3
0 quarters
|
|
5168
Blink Charging
BLNK
$74.4M
| $4 | ﹤0.01% |
7
-26
| -79% | -$15 |
2020 Q2
25 quarters
|
|
5169
Bio Green Med Solution Inc
BGMS
$5.7M
| $4 | ﹤0.01% |
+4
| New | +$4 |
2026 Q3
0 quarters
|
|
5170
Grove Collaborative
GROV
$46.5M
| $4 | ﹤0.01% |
4
-93
| -96% | -$99 |
2026 Q2
1 quarter
|
|
5171
Heart Test Laboratories
HSCS
$14.1M
| $4 | ﹤0.01% |
+1
| New | +$3 |
2026 Q3
0 quarters
|
|
5172
Abundia Global Impact Group
AGIG
$38M
| $4 | ﹤0.01% |
4
-801
| -100% | -$829 |
2026 Q2
1 quarter
|
|
5173
Coffee Holding Co
JVA
$27.7M
| $4 | ﹤0.01% |
+1
| New | +$4 |
2026 Q3
0 quarters
|
|
5174
AEye
LIDR
$40.5M
| $4 | ﹤0.01% |
+3
| New | +$4 |
2026 Q3
0 quarters
|
|
5175
MAIA Biotechnology
MAIA
$65.4M
| $4 | ﹤0.01% |
3
-4,149
| -100% | -$5.58K |
2026 Q2
1 quarter
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.